A new three dimensional biomimetic hydrogel to deliver factors secreted by human mesenchymal stem cells in spinal cord injury

Ilaria Caron, Filippo Rossi, Simonetta Papa, Rossella Aloe, Marika Sculco, Emanuele Mauri, Alessandro Sacchetti, Eugenio Erba, Nicolò Panini, Valentina Parazzi, Mario Barilani, Gianluigi Forloni, Giuseppe Perale, Lorenza Lazzari, Pietro Veglianese

Research output: Contribution to journalArticle

Abstract

Stem cell therapy with human mesenchymal stem cells (hMSCs) represents a promising strategy in spinal cord injury (SCI). However, both systemic and parenchymal hMSCs administrations show significant drawbacks as a limited number and viability of stem cells in situ. Biomaterials able to encapsulate and sustain hMSCs represent a viable approach to overcome these limitations potentially improving the stem cell therapy. In this study, we evaluate a new agarose/carbomer based hydrogel which combines different strategies to optimize hMSCs viability, density and delivery of paracrine factors. Specifically, we evaluate a new loading procedure on a lyophilized scaffold (soaked up effect) that reduces mechanical stress in encapsulating hMSCs into the hydrogel. In addition, we combine arginine-glycine-aspartic acid (RGD) tripeptide and 3D extracellular matrix deposition to increase the capacity to attach and maintain healthy hMSCs within the hydrogel over time. Furthermore, the fluidic diffusion from the hydrogel toward the injury site is improved by using a cling film that oriented efficaciously the delivery of paracrine factors in vivo. Finally, we demonstrate that an improved combination as here proposed of hMSCs and biomimetic hydrogel is able to immunomodulate significantly the pro-inflammatory environment in a SCI mouse model, increasing M2 macrophagic population and promoting a pro-regenerative environment in situ.

Original languageEnglish
Pages (from-to)135-147
Number of pages13
JournalBiomaterials
Volume75
DOIs
Publication statusPublished - Jan 1 2016

Fingerprint

Biomimetics
Hydrogel
Stem cells
Mesenchymal Stromal Cells
Spinal Cord Injuries
Hydrogels
Stem Cells
Cell- and Tissue-Based Therapy
Mechanical Stress
Biocompatible Materials
Aspartic Acid
Sepharose
Glycine
Extracellular Matrix
Arginine
Cell Survival
Cell Count
Fluidics
Biomaterials
Scaffolds

Keywords

  • Extracellular matrix
  • Human mesenchymal stem cells
  • Hydrogels
  • Inflammation
  • Macrophages
  • Spinal cord injury

ASJC Scopus subject areas

  • Biomaterials
  • Bioengineering
  • Ceramics and Composites
  • Mechanics of Materials
  • Biophysics

Cite this

A new three dimensional biomimetic hydrogel to deliver factors secreted by human mesenchymal stem cells in spinal cord injury. / Caron, Ilaria; Rossi, Filippo; Papa, Simonetta; Aloe, Rossella; Sculco, Marika; Mauri, Emanuele; Sacchetti, Alessandro; Erba, Eugenio; Panini, Nicolò; Parazzi, Valentina; Barilani, Mario; Forloni, Gianluigi; Perale, Giuseppe; Lazzari, Lorenza; Veglianese, Pietro.

In: Biomaterials, Vol. 75, 01.01.2016, p. 135-147.

Research output: Contribution to journalArticle

Caron, I, Rossi, F, Papa, S, Aloe, R, Sculco, M, Mauri, E, Sacchetti, A, Erba, E, Panini, N, Parazzi, V, Barilani, M, Forloni, G, Perale, G, Lazzari, L & Veglianese, P 2016, 'A new three dimensional biomimetic hydrogel to deliver factors secreted by human mesenchymal stem cells in spinal cord injury', Biomaterials, vol. 75, pp. 135-147. https://doi.org/10.1016/j.biomaterials.2015.10.024
Caron, Ilaria ; Rossi, Filippo ; Papa, Simonetta ; Aloe, Rossella ; Sculco, Marika ; Mauri, Emanuele ; Sacchetti, Alessandro ; Erba, Eugenio ; Panini, Nicolò ; Parazzi, Valentina ; Barilani, Mario ; Forloni, Gianluigi ; Perale, Giuseppe ; Lazzari, Lorenza ; Veglianese, Pietro. / A new three dimensional biomimetic hydrogel to deliver factors secreted by human mesenchymal stem cells in spinal cord injury. In: Biomaterials. 2016 ; Vol. 75. pp. 135-147.
@article{181abe65096547c59b3195eeac1d1a36,
title = "A new three dimensional biomimetic hydrogel to deliver factors secreted by human mesenchymal stem cells in spinal cord injury",
abstract = "Stem cell therapy with human mesenchymal stem cells (hMSCs) represents a promising strategy in spinal cord injury (SCI). However, both systemic and parenchymal hMSCs administrations show significant drawbacks as a limited number and viability of stem cells in situ. Biomaterials able to encapsulate and sustain hMSCs represent a viable approach to overcome these limitations potentially improving the stem cell therapy. In this study, we evaluate a new agarose/carbomer based hydrogel which combines different strategies to optimize hMSCs viability, density and delivery of paracrine factors. Specifically, we evaluate a new loading procedure on a lyophilized scaffold (soaked up effect) that reduces mechanical stress in encapsulating hMSCs into the hydrogel. In addition, we combine arginine-glycine-aspartic acid (RGD) tripeptide and 3D extracellular matrix deposition to increase the capacity to attach and maintain healthy hMSCs within the hydrogel over time. Furthermore, the fluidic diffusion from the hydrogel toward the injury site is improved by using a cling film that oriented efficaciously the delivery of paracrine factors in vivo. Finally, we demonstrate that an improved combination as here proposed of hMSCs and biomimetic hydrogel is able to immunomodulate significantly the pro-inflammatory environment in a SCI mouse model, increasing M2 macrophagic population and promoting a pro-regenerative environment in situ.",
keywords = "Extracellular matrix, Human mesenchymal stem cells, Hydrogels, Inflammation, Macrophages, Spinal cord injury",
author = "Ilaria Caron and Filippo Rossi and Simonetta Papa and Rossella Aloe and Marika Sculco and Emanuele Mauri and Alessandro Sacchetti and Eugenio Erba and Nicol{\`o} Panini and Valentina Parazzi and Mario Barilani and Gianluigi Forloni and Giuseppe Perale and Lorenza Lazzari and Pietro Veglianese",
year = "2016",
month = "1",
day = "1",
doi = "10.1016/j.biomaterials.2015.10.024",
language = "English",
volume = "75",
pages = "135--147",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - A new three dimensional biomimetic hydrogel to deliver factors secreted by human mesenchymal stem cells in spinal cord injury

AU - Caron, Ilaria

AU - Rossi, Filippo

AU - Papa, Simonetta

AU - Aloe, Rossella

AU - Sculco, Marika

AU - Mauri, Emanuele

AU - Sacchetti, Alessandro

AU - Erba, Eugenio

AU - Panini, Nicolò

AU - Parazzi, Valentina

AU - Barilani, Mario

AU - Forloni, Gianluigi

AU - Perale, Giuseppe

AU - Lazzari, Lorenza

AU - Veglianese, Pietro

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Stem cell therapy with human mesenchymal stem cells (hMSCs) represents a promising strategy in spinal cord injury (SCI). However, both systemic and parenchymal hMSCs administrations show significant drawbacks as a limited number and viability of stem cells in situ. Biomaterials able to encapsulate and sustain hMSCs represent a viable approach to overcome these limitations potentially improving the stem cell therapy. In this study, we evaluate a new agarose/carbomer based hydrogel which combines different strategies to optimize hMSCs viability, density and delivery of paracrine factors. Specifically, we evaluate a new loading procedure on a lyophilized scaffold (soaked up effect) that reduces mechanical stress in encapsulating hMSCs into the hydrogel. In addition, we combine arginine-glycine-aspartic acid (RGD) tripeptide and 3D extracellular matrix deposition to increase the capacity to attach and maintain healthy hMSCs within the hydrogel over time. Furthermore, the fluidic diffusion from the hydrogel toward the injury site is improved by using a cling film that oriented efficaciously the delivery of paracrine factors in vivo. Finally, we demonstrate that an improved combination as here proposed of hMSCs and biomimetic hydrogel is able to immunomodulate significantly the pro-inflammatory environment in a SCI mouse model, increasing M2 macrophagic population and promoting a pro-regenerative environment in situ.

AB - Stem cell therapy with human mesenchymal stem cells (hMSCs) represents a promising strategy in spinal cord injury (SCI). However, both systemic and parenchymal hMSCs administrations show significant drawbacks as a limited number and viability of stem cells in situ. Biomaterials able to encapsulate and sustain hMSCs represent a viable approach to overcome these limitations potentially improving the stem cell therapy. In this study, we evaluate a new agarose/carbomer based hydrogel which combines different strategies to optimize hMSCs viability, density and delivery of paracrine factors. Specifically, we evaluate a new loading procedure on a lyophilized scaffold (soaked up effect) that reduces mechanical stress in encapsulating hMSCs into the hydrogel. In addition, we combine arginine-glycine-aspartic acid (RGD) tripeptide and 3D extracellular matrix deposition to increase the capacity to attach and maintain healthy hMSCs within the hydrogel over time. Furthermore, the fluidic diffusion from the hydrogel toward the injury site is improved by using a cling film that oriented efficaciously the delivery of paracrine factors in vivo. Finally, we demonstrate that an improved combination as here proposed of hMSCs and biomimetic hydrogel is able to immunomodulate significantly the pro-inflammatory environment in a SCI mouse model, increasing M2 macrophagic population and promoting a pro-regenerative environment in situ.

KW - Extracellular matrix

KW - Human mesenchymal stem cells

KW - Hydrogels

KW - Inflammation

KW - Macrophages

KW - Spinal cord injury

UR - http://www.scopus.com/inward/record.url?scp=84946422632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946422632&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2015.10.024

DO - 10.1016/j.biomaterials.2015.10.024

M3 - Article

VL - 75

SP - 135

EP - 147

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

ER -